Biora Therapeutics Inc. Common Stock (NASDAQ: PROG)
Company Name:Biora Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: PROG
Class Period Start:06/22/2020
Class Period End (inclusive):08/28/2020
Filing Deadline:10/27/2020
According to the Complaint, Progenity, Inc. is a biotechnology company focused on developing and commercializing molecular testing products and precision medicine applications. The Company provides in vitro molecular tests designed to assist parents in making informed decisions related to family planning, pregnancy, and complex disease diagnosis.